[Federal Register: October 8, 2008 (Volume 73, Number 196)]
[Notices]               
[Page 58979]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08oc08-86]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 8, 2008, National 
Center for Natural Products Research--NIDA MProject, University of 
Mississippi, 135 Coy Waller Complex, University, Mississippi 38677, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed in schedule I:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
------------------------------------------------------------------------

    The company plans to cultivate marihuana for the National Institute 
on Drug Abuse for research approved by the Department of Health and 
Human Services.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 
22152; and must be filed no later than December 8, 2008.

    Dated: October 2, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-23816 Filed 10-7-08; 8:45 am]

BILLING CODE 4410-09-P